Key Safety Considerations The safety of GLP-1 receptor agonists in older adults is a nuanced question that depends on individual patient characteristics, comorbidities, and careful clinical assessment
Peptide therapy is provided only after medical consultation by a licensed provider.
Rassman WR, Bernstein RM, McClellan R, Jones R, Worton E, Uyttendaele H
The looming government shutdown on Wednesday is another unknown, though a former CMS official says it should not disrupt the open enrollment period because funding for the contractors involved in the process would already have been allocated
In consideration of the comments received related to concerns about low response rates and survey fatigue, we are not adopting the Information Transfer PRO-PM at this time